Ontology highlight
ABSTRACT: Background
Drug-coated balloons (DCB) have promising results in the management of in-stent restenosis (ISR), still their role remains a major challenge, and not well established in contemporary clinical practice.Aims
To provide a comprehensive appraisal of the efficacy and safety of DCBs in patients with in-stent restenosis (ISR).Methods
We searched PubMed, Scopus, web of Science, Ovid, and Cochrane Central from inception until 30 March, 2023. We included randomized controlled trials (RCTs) that compared DCB versus DES in ISR patients. Our primary endpoints were major adverse cardiac events (MACE) and late lumen loss (LLL). Secondary clinical endpoints were all-cause death, cardiac death, MI, TLR, TVR, and stent thrombosis, and angiographic outcomes were MLD, and in
SUBMITTER: Abdelaziz A
PROVIDER: S-EPMC11539716 | biostudies-literature | 2024 Nov
REPOSITORIES: biostudies-literature